IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 196 filers reported holding IMPAX LABORATORIES INC in Q3 2015. The put-call ratio across all filers is 2.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $30,000 | +114.3% | 1,546 | +100.3% | 0.00% | – |
Q4 2017 | $14,000 | -99.4% | 772 | -99.4% | 0.00% | -100.0% |
Q3 2017 | $2,461,000 | +27244.4% | 121,280 | +21752.3% | 0.00% | – |
Q2 2017 | $9,000 | +80.0% | 555 | +54.2% | 0.00% | – |
Q1 2017 | $5,000 | +400.0% | 360 | +373.7% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 76 | +26.7% | 0.00% | – |
Q3 2016 | $1,000 | -91.7% | 60 | -85.6% | 0.00% | – |
Q2 2016 | $12,000 | -40.0% | 417 | -33.5% | 0.00% | – |
Q1 2016 | $20,000 | -23.1% | 627 | +2.5% | 0.00% | – |
Q4 2015 | $26,000 | +18.2% | 612 | 0.0% | 0.00% | – |
Q3 2015 | $22,000 | -21.4% | 612 | +2.3% | 0.00% | – |
Q2 2015 | $28,000 | -88.0% | 598 | -88.1% | 0.00% | – |
Q1 2015 | $234,000 | +3242.9% | 5,020 | +2181.8% | 0.00% | – |
Q4 2014 | $7,000 | +40.0% | 220 | 0.0% | 0.00% | – |
Q3 2014 | $5,000 | -28.6% | 220 | 0.0% | 0.00% | – |
Q2 2014 | $7,000 | +16.7% | 220 | 0.0% | 0.00% | – |
Q1 2014 | $6,000 | +100.0% | 220 | +58.3% | 0.00% | – |
Q3 2013 | $3,000 | 0.0% | 139 | 0.0% | 0.00% | – |
Q2 2013 | $3,000 | – | 139 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |